...
首页> 外文期刊>Neurological sciences >Posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus after cessation of oral prednisone
【24h】

Posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus after cessation of oral prednisone

机译:系统性红斑狼疮患者停止口服泼尼松后后可逆性脑病综合征

获取原文
获取原文并翻译 | 示例
           

摘要

Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder that is first described by Hinchey and colleagues in 1996 [1]. It is associated with various clinical features such as hypertension, seizures, headache, visual changes and conscious disturbance [2]. In previous reports, PRES have been reported in patients with SLE. The use of immunosuppressive drugs was an established cause of PRES in SLE [3]. Here we describe a case of PRES due to cessation of oral prednisone. To the best of our knowledge, this is the first report of PRES due to cessation of oral prednisone.
机译:后可逆性脑病综合征(PRES)是一种神经系统疾病,由Hinchey及其同事于1996年首次描述[1]。它与多种临床特征有关,例如高血压,癫痫发作,头痛,视力改变和意识障碍[2]。在以前的报道中,已经报道了SLE患者中的PRES。免疫抑制药物的使用是SLE中PRES的既定原因[3]。在这里,我们描述了由于停止口服泼尼松而引起的PRES病例。据我们所知,这是由于停止口服泼尼松而引起的PRES的首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号